These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 30507062)

  • 21. Elevated levels of human beta-defensin 2 and human neutrophil peptides in systemic lupus erythematosus.
    Vordenbäumen S; Fischer-Betz R; Timm D; Sander O; Chehab G; Richter J; Bleck E; Schneider M
    Lupus; 2010 Dec; 19(14):1648-53. PubMed ID: 20724351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low serum uromodulin levels and their association with lupus flares.
    David BL; Ivan GJ; Emilio PE; Daniela MJ; Betsabe CH; Luisa VM; Selene FN; Guadalupe AEA; Miriam SA; Alfredo C; Arturo NC; Mercedes HD; German CE; Gonzalez-Lopez L
    PLoS One; 2022; 17(10):e0276481. PubMed ID: 36301848
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum levels of P-glycoprotein and persistence of disease activity despite treatment in patients with systemic lupus erythematosus.
    Perez-Guerrero EE; Gamez-Nava JI; Muñoz-Valle JF; Cardona-Muñoz EG; Bonilla-Lara D; Fajardo-Robledo NS; Nava-Zavala AH; Garcia-Cobian TA; Rincón-Sánchez AR; Murillo-Vazquez JD; Cardona-Müller D; Vazquez-Villegas ML; Totsuka-Sutto SE; Gonzalez-Lopez L
    Clin Exp Med; 2018 Feb; 18(1):109-117. PubMed ID: 28243944
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Are interferon-related biomarkers advantageous for monitoring disease activity in systemic lupus erythematosus? A longitudinal benchmark study.
    Rose T; Grützkau A; Klotsche J; Enghard P; Flechsig A; Keller J; Riemekasten G; Radbruch A; Burmester GR; Dörner T; Hiepe F; Biesen R
    Rheumatology (Oxford); 2017 Sep; 56(9):1618-1626. PubMed ID: 28859328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus.
    Mahmoud RA; El-Gendi HI; Ahmed HH
    Clin Biochem; 2005 Feb; 38(2):134-41. PubMed ID: 15642275
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-C1q autoantibodies as markers of renal involvement in childhood-onset systemic lupus erythematosus.
    Picard C; Lega JC; Ranchin B; Cochat P; Cabrera N; Fabien N; Belot A
    Pediatr Nephrol; 2017 Sep; 32(9):1537-1545. PubMed ID: 28343355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum free light chains, interferon-alpha, and interleukins in systemic lupus erythematosus.
    Jolly M; Francis S; Aggarwal R; Mikolaitis RA; Niewold TB; Chubinskaya S; Block JA; Scanzello C; Sequeira W
    Lupus; 2014 Aug; 23(9):881-8. PubMed ID: 24786785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interferon alpha gene expression and serum level association with low vitamin D levels in Egyptian female patients with systemic lupus erythematosus.
    Abdel Galil SM; El-Shafey AM; Abdul-Maksoud RS; El-Boshy M
    Lupus; 2018 Feb; 27(2):199-209. PubMed ID: 28659049
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating plasma levels of nucleosomes in patients with systemic lupus erythematosus: correlation with serum antinucleosome antibody titers and absence of clear association with disease activity.
    Amoura Z; Piette JC; Chabre H; Cacoub P; Papo T; Wechsler B; Bach JF; Koutouzov S
    Arthritis Rheum; 1997 Dec; 40(12):2217-25. PubMed ID: 9416860
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Measuring serum levels of high-mobility group box 1 by enzyme-linked immunosorbent assay does not identify bacterial infections in patients with systemic lupus erythematosus.
    Tang KT; Hsieh TY; Chen YM; Hsieh CW; Chen YH; Chen DY
    Lupus; 2014 Aug; 23(9):926-34. PubMed ID: 24704776
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of serum C-reactive protein levels with lupus disease activity in the absence of measurable interferon-α and a C-reactive protein gene variant.
    Enocsson H; Sjöwall C; Kastbom A; Skogh T; Eloranta ML; Rönnblom L; Wetterö J
    Arthritis Rheumatol; 2014 Jun; 66(6):1568-73. PubMed ID: 24574329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathways of impending disease flare in African-American systemic lupus erythematosus patients.
    Munroe ME; Vista ES; Merrill JT; Guthridge JM; Roberts VC; James JA
    J Autoimmun; 2017 Mar; 78():70-78. PubMed ID: 28162788
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-nucleosome and anti-chromatin antibodies are present in active systemic lupus erythematosus but not in the cutaneous form of the disease.
    Souza A; da Silva LM; Oliveira FR; Roselino AM; Louzada-Junior P
    Lupus; 2009 Mar; 18(3):223-9. PubMed ID: 19213860
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum levels of soluble CD40 ligand at flare and at remission in patients with systemic lupus erythematosus.
    Urquizu-Padilla M; Balada E; Cortés F; Pérez EH; Vilardell-Tarrés M; Ordi-Ros J
    J Rheumatol; 2009 May; 36(5):953-60. PubMed ID: 19332622
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Brief Report: Interleukin-38 Exerts Antiinflammatory Functions and Is Associated With Disease Activity in Systemic Lupus Erythematosus.
    Rudloff I; Godsell J; Nold-Petry CA; Harris J; Hoi A; Morand EF; Nold MF
    Arthritis Rheumatol; 2015 Dec; 67(12):3219-25. PubMed ID: 26314375
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Soluble urokinase plasminogen activator receptor levels reflect organ damage in systemic lupus erythematosus.
    Enocsson H; Wetterö J; Skogh T; Sjöwall C
    Transl Res; 2013 Nov; 162(5):287-96. PubMed ID: 23916811
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Th1/Th2 cytokines in patients with systemic lupus erythematosus: is tumor necrosis factor alpha protective?
    Gómez D; Correa PA; Gómez LM; Cadena J; Molina JF; Anaya JM
    Semin Arthritis Rheum; 2004 Jun; 33(6):404-13. PubMed ID: 15190525
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating anti-double-stranded DNA antibody-secreting cells in patients with systemic lupus erythematosus: a novel biomarker for disease activity.
    Hanaoka H; Okazaki Y; Satoh T; Kaneko Y; Yasuoka H; Seta N; Kuwana M
    Lupus; 2012 Oct; 21(12):1284-93. PubMed ID: 22740429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevated semaphorin5A in systemic lupus erythematosus is in association with disease activity and lupus nephritis.
    Du Y; Wu X; Chen M; Wang W; Xv W; Ye L; Wu D; Xue J; Sun W; Luo J; Wu H
    Clin Exp Immunol; 2017 May; 188(2):234-242. PubMed ID: 28063160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Axl, Ferritin, Insulin-Like Growth Factor Binding Protein 2, and Tumor Necrosis Factor Receptor Type II as Biomarkers in Systemic Lupus Erythematosus.
    Mok CC; Ding HH; Kharboutli M; Mohan C
    Arthritis Care Res (Hoboken); 2016 Sep; 68(9):1303-9. PubMed ID: 26749069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.